Rigel Pharmaceuticals (RIGL) Tax Provisions (2021 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Tax Provisions came in at $3.0 million in Q1 2026, up 4520.0% year-on-year from $65000.0 in Q1 2025, and up 101.22% quarter-over-quarter from -$245.4 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Tax Provisions (2021 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Tax Provisions rose 4520.0% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was -$242.3 million, a 25708.77% decrease from a year earlier, with the FY2025 full-year figure at -$245.2 million, down 27931.67% from the prior year.
- Tax Provisions rose to $3.0 million in Q1 2026 per RIGL's latest filing, from -$245.4 million in the prior quarter.
- Across five years, Tax Provisions topped out at $3.0 million in Q1 2026 and bottomed at -$245.4 million in Q4 2025.
- The 3-year median for Tax Provisions is $217000.0 (2025), against an average of -$40.2 million.
- Across the five-year window, Tax Provisions slumped 27949.15% in 2025 and soared 4520.0% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $881000.0 in 2024, then slumped by 27949.15% to -$245.4 million in 2025, then soared by 101.22% to $3.0 million in 2026.
- Per Business Quant, the three latest RIGL Tax Provisions figures stand at $3.0 million (Q1 2026), -$245.4 million (Q4 2025), and -$280000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | -245.35 Mn |
| Sep 30, 2025 | -280,000.00 |
| Jun 30, 2025 | 369,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | -136,000.00 |
| Jun 30, 2021 | -1.00 Mn |
| Mar 31, 2021 | 1.80 Mn |